The effect of continuous subcutaneous insulin infusion therapy (CSIIT) on oxidative stress in Korean type II diabetic patients

被引：0
|
作者：
Choi, SB
Choi, WK
Park, S
机构：
来源：
DIABETES | 1998年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1641
引用
收藏
页码：A429 / A429
页数：1
相关论文
共 50 条
  • [41] ENDURANCE EXERCISE IN TYPE-1 DIABETIC-PATIENTS TREATED BY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    SCHEEN, AJ
    JANDRAIN, BJ
    PIRNAY, F
    LACROIX, M
    MOSORA, F
    LEFEBVRE, PJ
    DIABETOLOGIA, 1993, 36 : A21 - A21
  • [42] Comparison between lispro insulin and regular insulin in continuous subcutaneous insulin infusion treatment in Korea type 2 diabetic patients
    Choi, SB
    Kim, SD
    Park, SM
    DIABETES, 2000, 49 : A355 - A355
  • [43] Comparison of effectiveness of continuous subcutaneous insulin infusion with daily insulin injection in a Chinese population of Type I diabetic patients
    Yi, Qianqian
    Wu, Zhiyu
    Dong, Junhua
    Zhang, Ningning
    Li, Qiuyue
    Gao, Na
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (07) : 1517 - 1522
  • [44] Diurnal variation of carbohydrate insulin ratio in adult type 1 diabetic patients treated with continuous subcutaneous insulin infusion
    Nakamura, Tomoaki
    Hirota, Yushi
    Hashimoto, Naoko
    Matsuda, Tomokazu
    Takabe, Michinori
    Sakaguchi, Kazuhiko
    Ogawa, Wataru
    Seino, Susumu
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (01) : 48 - 50
  • [45] Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs
    Guerci, B
    Floriot, M
    Böhme, P
    Durain, D
    Benichou, M
    Jellimann, S
    Drouin, P
    DIABETES CARE, 2003, 26 (03) : 582 - 589
  • [46] THE EFFECT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION TREATMENT ON PROLIFERATIVE DIABETIC-RETINOPATHY
    SEGATO, T
    MIDENA, E
    PIERMAROCCHI, S
    CREPALDI, G
    TIENGO, A
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1982, 94 (05) : 685 - 686
  • [47] THE PHARMACOKINETICS OF INSULIN AFTER CONTINUOUS SUBCUTANEOUS INFUSION OR BOLUS SUBCUTANEOUS INJECTION IN DIABETIC-PATIENTS
    KOBAYASHI, T
    SAWANO, S
    ITOH, T
    KOSAKA, K
    HIRAYAMA, H
    KASUYA, Y
    DIABETES, 1983, 32 (04) : 331 - 336
  • [48] Good metabolic control with a continuous subcutaneous insulin infusion (CSII) in type 2 diabetic patients uncontrolled by insulin optimisation
    Donnet, J. -P.
    Courreges, J-P.
    Clavel, S.
    Gabreau, T.
    Gouet, D.
    Verlet, E.
    Cosson, E.
    Jan, P.
    Cirette, B.
    Leutenegger, E.
    DIABETOLOGIA, 2010, 53
  • [49] Effects of Insulin Therapy with Continuous Subcutaneous Insulin Infusion (CSII) in Diabetic Patients: Comparison with Multi-daily Insulin Injections Therapy (MDI)
    Derosa, Giuseppe
    Maffioli, Pamela
    D'Angelo, Angela
    Salvadeo, Sibilla A. T.
    Ferrari, Ilaria
    Fogari, Elena
    Mereu, Roberto
    Gravina, Alessia
    Palumbo, Ilaria
    Randazzo, Sabrina
    Cicero, Arrigo F. G.
    ENDOCRINE JOURNAL, 2009, 56 (04) : 571 - 578
  • [50] Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII)
    Reichel, A
    Schwarz, J
    Schulze, J
    Licinio, J
    Wong, ML
    Bornstein, SR
    MOLECULAR PSYCHIATRY, 2005, 10 (11) : 975 - 976
12345